Literature DB >> 16542182

The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.

Faith B Dickerson1, John J Boronow, Cassie Stallings, Andrea E Origoni, Sara Cole, Flora Leister, Bogdana Krivogorsky, Robert H Yolken.   

Abstract

BACKGROUND: Bipolar disorder is associated with deficits in cognitive functioning. The etiology of cognitive impairment in bipolar disorder may relate to both genetic and environmental factors. A valine/methionine polymorphism of the catechol O-methyltransferase gene at amino acid 158 (COMT Val158Met polymorphism) has been identified as a risk factor for cognitive impairment in schizophrenia. Serological evidence of infection with herpes simplex virus type 1 (HSV-1) has also been identified as a risk factor for cognitive impairment in bipolar disorder.
METHODS: We used Taqman technology to measure COMT Val158Met alleles in 107 individuals with bipolar disorder and in 95 controls. We also measured antibodies to HSV-1 in sera obtained from the same individuals. Cognitive functioning was assessed with the Repeatable Battery for the Assessment of Neuropsychological Status and the Letter-Number Sequencing Test. The effects of the COMT Val158Met polymorphism and antibodies to HSV-1 on cognitive functioning were analyzed with multinomial logistic regressions.
RESULTS: The COMT Val158Val genotype and serological evidence of infection with HSV-1 are independent risk factors for cognitive impairment in individuals with bipolar disorder, particularly in the domains of immediate and delayed memory. Individuals with bipolar disorder with the COMT158 Val/Val genotype and serological evidence of HSV-1 infection were more than 85 times more likely to be in the lowest quintile of cognitive functioning when compared with the highest quintile when controlling for potential confounding variables such as symptom severity and education. Control individuals did not display this association.
CONCLUSION: Both the COMT Val158Met polymorphism and serological evidence of HSV-1 infection affect cognitive functioning in individuals with bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542182     DOI: 10.1111/j.1399-5618.2006.00288.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  11 in total

1.  The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis.

Authors:  Zhao Zhang; Klaus Lindpaintner; Ronglin Che; Zangdong He; Peng Wang; Ping Yang; Guoyin Feng; Lin He; Yongyong Shi
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

Review 2.  eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?

Authors:  Christopher J Carter
Journal:  Schizophr Bull       Date:  2007-02-27       Impact factor: 9.306

3.  Circulating miRNAs as Potential Biomarkers for Patient Stratification in Bipolar Disorder: A Combined Review and Data Mining Approach.

Authors:  Alexandra R Clausen; Simon Durand; Rasmus L Petersen; Nicklas H Staunstrup; Per Qvist
Journal:  Genes (Basel)       Date:  2022-06-10       Impact factor: 4.141

Review 4.  Imaging phenotypes of major depressive disorder: genetic correlates.

Authors:  J B Savitz; W C Drevets
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

5.  The COMT Val158Met Polymorphism and Exploratory Behavior in Bipolar Mania.

Authors:  Arpi Minassian; Jared W Young; Mark A Geyer; John R Kelsoe; William Perry
Journal:  Mol Neuropsychiatry       Date:  2017-11-22

6.  Bipolar disorder: clinical perspectives and implications with cognitive dysfunction and dementia.

Authors:  R Lopes; L Fernandes
Journal:  Depress Res Treat       Date:  2012-05-28

7.  Association between exposure to HSV1 and cognitive functioning in a general population of adolescents. The TRAILS study.

Authors:  Iris Jonker; Hans C Klein; Hester E Duivis; Robert H Yolken; Judith G M Rosmalen; Robert A Schoevers
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

8.  Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review.

Authors:  Błażej Misiak; Filip Stramecki; Łukasz Gawęda; Katarzyna Prochwicz; Maria M Sąsiadek; Ahmed A Moustafa; Dorota Frydecka
Journal:  Mol Neurobiol       Date:  2017-08-18       Impact factor: 5.590

9.  Antipsychotic medications and cognitive functioning in bipolar disorder: moderating effects of COMT Val108/158 Met genotype.

Authors:  Baer Arts; Claudia J P Simons; Marjan Drukker; Jim van Os
Journal:  BMC Psychiatry       Date:  2013-02-19       Impact factor: 3.630

10.  Chemokine and Chemokine Receptor Polymorphisms in Bipolar Disorder.

Authors:  Damla Tokac; Erdem Tuzun; Huseyin Gulec; Vuslat Yılmaz; Elif Sinem Bireller; Bedia Cakmakoglu; Cem Ismail Kucukali
Journal:  Psychiatry Investig       Date:  2016-09-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.